α2-Adrenergic Agonists or Stimulants for Preschool-Age Children With Attention-Deficit/Hyperactivity Disorder.

ABSTRACT:

Importance

Attention-deficit/hyperactivity disorder (ADHD) is diagnosed in approximately 2.4% of preschool-age children. Stimulants are recommended as first-line medication treatment. However, up to 25% of preschool-age children with ADHD are treated with α2-adrenergic agonist medications, despite minimal evidence about their efficacy or adverse effects in this age range.

Objective

To determine the frequency of reported improvement in ADHD symptoms and adverse effects associated with α2-adrenergic agonists and stimulant medication for initial ADHD medication treatment in preschool-age children.

Design, setting, and participants

Retrospective electronic health record review. Data were obtained from health records of children seen at 7 outpatient developmental-behaviora

SUBMITTER: Harstad E 

PROVIDER: S-EPMC8097628 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature